- Report
- October 2024
- 191 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- March 2025
- 179 Pages
Global
From €4699EUR$4,950USD£3,964GBP
- Report
- May 2022
- 86 Pages
Global
From €3500EUR$3,949USD£3,056GBP
- Report
- January 2025
- 132 Pages
Global
From €902EUR$950USD£761GBP
The Cardiopulmonary Autotransfusion System (CPAT) is a cardiovascular device used to collect, store, and reinfuse a patient's own blood during cardiac surgery. It is designed to reduce the need for donor blood transfusions, which can carry risks such as infection and immunological reactions. CPAT systems typically consist of a blood collection device, a blood storage device, and a blood reinfusion device. The collection device is used to collect the patient's blood during surgery, while the storage device is used to store the blood until it is needed. The reinfusion device is used to reinfuse the patient's blood back into the patient's body.
CPAT systems are used in a variety of cardiac surgeries, including coronary artery bypass grafting, valve replacement, and heart transplantation. They are also used in other types of surgeries, such as orthopedic and plastic surgery. CPAT systems are becoming increasingly popular due to their ability to reduce the need for donor blood transfusions and the associated risks.
Some companies in the CPAT market include Haemonetics Corporation, Fresenius Medical Care, and Terumo Corporation. Show Less Read more